Borqs Technologies, Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Borqs Technologies, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | $154.31M | Apr 2, 2018 |
| FY2017 | Dec 31, 2016 | $120.59M | Apr 2, 2018 |
| FY2017 | Dec 31, 2015 | $75.07M | Apr 2, 2018 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | $27.17M | Apr 2, 2018 |
| FY2017 | Dec 31, 2016 | $25.15M | Apr 2, 2018 |
| FY2017 | Dec 31, 2015 | $17.07M | Apr 2, 2018 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | ($12.50M) | Apr 2, 2018 |
| FY2017 | Jun 30, 2017 | ($1.77M) | Aug 17, 2017 |
| FY2017 | Dec 31, 2016 | $3.23M | Apr 2, 2018 |
| FY2017 | Jun 30, 2016 | ($392.3K) | Aug 17, 2017 |
| FY2017 | Dec 31, 2015 | $2.11M | Apr 2, 2018 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | ($7.93M) | Apr 2, 2018 |
| FY2017 | Jun 30, 2017 | ($1.97M) | Aug 17, 2017 |
| FY2017 | Dec 31, 2016 | $5.24M | Apr 2, 2018 |
| FY2017 | Jun 30, 2016 | ($469.5K) | Aug 17, 2017 |
| FY2017 | Dec 31, 2015 | $713.0K | Apr 2, 2018 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | $6.44M | Apr 2, 2018 |
| FY2017 | Dec 31, 2016 | $5.74M | Apr 2, 2018 |
| FY2017 | Dec 31, 2015 | $7.21M | Apr 2, 2018 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | ($14.90M) | Apr 2, 2018 |
| FY2017 | Jun 30, 2017 | ($1.02M) | Aug 17, 2017 |
| FY2017 | Dec 31, 2016 | ($9.37M) | Apr 2, 2018 |
| FY2017 | Jun 30, 2016 | ($376.0K) | Aug 17, 2017 |
| FY2017 | Dec 31, 2015 | $1.63M | Apr 2, 2018 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | $842.0K | Apr 2, 2018 |
| FY2017 | Dec 31, 2016 | $494.0K | Apr 2, 2018 |
| FY2017 | Dec 31, 2015 | $798.0K | Apr 2, 2018 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | $148.83M | Apr 2, 2018 |
| FY2017 | Jun 30, 2017 | $53.90M | Aug 17, 2017 |
| FY2017 | Dec 31, 2016 | $78.03M | Apr 2, 2018 |
| FY2017 | Jun 30, 2016 | $60.43M | Aug 17, 2017 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | $101.75M | Apr 2, 2018 |
| FY2017 | Jun 30, 2017 | $1.51M | Aug 17, 2017 |
| FY2017 | Dec 31, 2016 | $64.52M | Apr 2, 2018 |
| FY2017 | Jun 30, 2016 | $270.3K | Aug 17, 2017 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | $47.08M | Apr 2, 2018 |
| FY2017 | Jun 30, 2017 | $5.00M | Aug 17, 2017 |
| FY2017 | Dec 31, 2016 | ($55.35M) | Apr 2, 2018 |
| FY2017 | Jun 30, 2016 | $5.00M | Aug 17, 2017 |
| FY2017 | Dec 31, 2015 | ($55.40M) | Apr 2, 2018 |
| FY2017 | Dec 31, 2014 | ($52.29M) | Apr 2, 2018 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | $736.0K | Apr 2, 2018 |
| FY2017 | Dec 31, 2016 | $693.0K | Apr 2, 2018 |
| FY2017 | Dec 31, 2015 | $741.0K | Apr 2, 2018 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | ($74.16M) | Apr 2, 2018 |
| FY2017 | Jun 30, 2017 | ($2.16M) | Aug 17, 2017 |
| FY2017 | Dec 31, 2016 | ($54.71M) | Apr 2, 2018 |
| FY2017 | Jun 30, 2016 | ($392.3K) | Aug 17, 2017 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | $13.06M | Apr 2, 2018 |
| FY2017 | Jun 30, 2017 | $319.3K | Aug 17, 2017 |
| FY2017 | Dec 31, 2016 | $3.61M | Apr 2, 2018 |
| FY2017 | Sep 30, 2016 | $5.48M | Apr 2, 2018 |
| FY2017 | Jun 30, 2016 | $461.9K | Aug 17, 2017 |
| FY2017 | Dec 31, 2015 | $7.79M | Apr 2, 2018 |
| FY2017 | Dec 31, 2014 | $13.42M | Apr 2, 2018 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | $18.08M | Apr 2, 2018 |
| FY2017 | Dec 31, 2016 | $12.18M | Apr 2, 2018 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | (1) | Apr 2, 2018 |
| FY2017 | Dec 31, 2016 | 0 | Apr 2, 2018 |
| FY2017 | Dec 31, 2015 | 0 | Apr 2, 2018 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | (1) | Apr 2, 2018 |
| FY2017 | Dec 31, 2016 | 0 | Apr 2, 2018 |
| FY2017 | Dec 31, 2015 | 0 | Apr 2, 2018 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | 30.80M | Apr 2, 2018 |
| FY2017 | Jun 30, 2017 | 2.56M | Aug 17, 2017 |
| FY2017 | Dec 31, 2016 | 4.22M | Apr 2, 2018 |
| FY2017 | Jun 30, 2016 | 2.42M | Aug 17, 2017 |